个人信息
Personal Information
联系方式
Contact Information
个人简介
Personal Profile
刘达,吉林大学博士研究生,长春中医药大学教授,博士研究生导师。吉林省优秀创新创业人才,吉林省D类人才。主要从事天然药物的生物功效研究及中药健康产品研发。主持科研课题15项,其中国家自然科学基金1项,中国博士后科学基金2项,省部级科研项目3项,企业合作项目1项,总经费515.5万元;发表科研论文70篇、中文核心及科技核心等论文7篇,其中第一作者或通讯发表SCI论文33篇;公开发明专利10项,其中授权发明专利5项;获省级科技进步二等奖1项、自然科学二等奖1项、吉林省优秀青年创新创业团队1项、首届博士后创新创业大赛吉林省二等奖、第二届全国博士后创新创业大赛银奖、吉林省优秀青年创新创业团队、中国(广东)中山海外博士后创新赛铜奖等奖项;指导学生在“挑战杯”中国大学生创业计划竞赛、“互联网+“大学生创新创业大赛、全国大学生生命科学创新创业大赛等竞赛中获得国家级省级奖项10余次。
上传附件
支持扩展名:.rar .zip .doc .docx .pdf .jpg .png .jpeg上传附件
支持扩展名:.rar .zip .doc .docx .pdf .jpg .png .jpeg上传附件
支持扩展名:.rar .zip .doc .docx .pdf .jpg .png .jpeg1.人参外泌体调控SIRT5抑制心肌细胞肥大中的表观遗传调控模式研究,吉林省自然科学基金(面上项目),项目负责人,课题经费10万元,2024/01-2026/12
2.间充质干细胞外泌体关键技术研究研究及医药健康产品研发,横向课题,项目负责人,课题经费50万元,2023/01-2025/12
3.人参外泌体抗衰老作用及医药健康产品开发,吉林省博士后择优资助项目,项目负责人,课题经费5万元,2021/01-2023/12
4.人参皂苷Rd在心肌细胞肥大过程中对P300的autoacetylation下调的表观遗传调控机制研究,国家自然科学基金青年基金,项目负责人,课题经费21万元,2019/01/01-2021/12/31
5.中国博士后科学基金第67批面上资助,项目负责人,课题经费8万元,2020.09-2022.09
6.中国博士后科学基金第13批特别资助(站中),项目负责人,课题经费18万元,2020/09-2022/09
7.人参皂苷Rd治疗心肌肥厚过程中调控组蛋白乙酰化的作用机制研究,吉林省科技厅优秀青年基金,项目负责人,课题经费10万元,2018/01-2019/12
8.基于类脂质体技术的人参系列化妆品的开发,吉林省科学技术厅重点科技成果转化项目,项目负责人,课题经费50万元,2017/1-2019/12
1.NLRP3 Inflammasome-Mediated Osteoarthritis: The Role of Epigenetics;Yuzhou Liu; Ying Wang; Ping Yan; Ning Cui; Kejin Xu ... Da Liu ...202514(1):71Biology-Basel;IF=3.6
2.Oral Nanoformulations in Cardiovascular Medicine: Advances in Atherosclerosis Treatment;Xu Sun; Xushuang Jia; Zhaolin Tan; Dongmei Fan; Meiqi Chen ... Da Liu ...202417(7):919;Pharmaceuticals;IF: 4.3
3.Potential Application of Self-Assembled Peptides and Proteins in Breast Cancer and Cervical Cancer.Shidong Zhang; Chen Meiqi; Geng Zijun; Tianjia Liu; Shuangyang Li ... Liu Da* ...202324(23):17056INTERNATIONAL JOURNAL OF MOLECULAR SCIENCESIF: 4.9
4.Regeneration and anti-inflammatory effects of stem cells and their extracellular vesicles in gynecological diseases;Zheng Xu; Zhao Dan; Yang Liu; Ye Jin; Tianjia Liu* ... Liu Da* ...2023168:115739;BIOMEDICINE & PHARMACOTHERAPY;IF: 6.9
5.Role of the NLRP3 inflammasome in gynecological disease;Zheng Xu; Zhao Dan; Ye Jin*; Yang Liu*; Liu Da*;2023166:115393BIOMEDICINE & PHARMACOTHERAPYIF: 6.9
6.Application of seaweed polysaccharide in bone tissue regeneration;Ye Jin; Qixuan Yu; Shuangyang Li; Tianli Chen*; Liu Da*;202310Frontiers in Marine ScienceIF: 2.8
7.Decreased acetylation of HDGF improves oviduct production in Rana dybowskii, Rana amurensis, and Rana huanrenensis.;Liu Da; Qirong Li; Tianjia Liu; Yi Zhang; Zheng Ran ...;202347:101102Comparative Biochemistry and Physiology D-Genomics & Proteomics;IF: 2.2
9.Self-Assembled Peptide Hydrogels in Regenerative Medicine;Shuangyang Li; Qixuan Yu; Li Hongpeng; Chen Meiqi; Ye Jin* ... Liu Da* ...;20239(8):653Gels;IF: 5.0
10.Natural Products Treat Colorectal Cancer by Regulating miRNA;Shuoxi Guo; Chen Meiqi; Shuangyang Li; Geng Zijun; Ye Jin* ... Liu Da* ...;202316(8):1122Pharmaceuticals;IF: 4.3
11.Histone Modification of Colorectal Cancer by Natural Products;Geng Zijun; Chen Meiqi; Qixuan Yu; Shuoxi Guo; Tianli Chen* ... Liu Da* ...;202316(8):1095Pharmaceuticals;IF: 4.3
12.Application of stem cells in regeneration medicine;Ye Jin; Shuangyang Li; Qixuan Yu; Tianli Chen*; Liu Da*
20234(4)MedComm;IF: 10.7
13.Cryptotanshinone, a Potential SIRT3 Inhibitor, Suppresses Colorectal Cancer Proliferation in vitro and in vivo;Dimeng Song; Fang Xiaoxue; Zhiyuan Sun; Zhidong Qiu; Liu Da ...;202318(8)Natural Product Communications;IF: 1.5
14.Large animal models in the study of gynecological diseases;Minghua Cui; Yuehui Liu; Xiaoping Men; Tao Li; Liu Da* ...;202311Frontiers in Cell and Developmental Biology;IF: 4.6
15.Gut microbiota: The key to the treatment of metabolic syndrome in traditional Chinese medicine - a case study of diabetes and nonalcoholic fatty liver disease;Bao Yang; Xiao Han; Liu Da*; Zhaolin Tan*; Deng Yongzhi*;202213;Frontiers in Immunology;IF: 5.7
17.Ginseng glycoprotein and ginsenoside facilitate anti UV damage effects in diabetic rats
Hu Shuang; Lulu Huo; Jing He; Ye Jin*; Deng Yongzhi* ... Liu Da* ...;202213;Frontiers in Pharmacology;IF: 4.4
18.Ginsenoside Rd protects transgenic Caenorhabditis elegans from β-amyloid toxicity by activating oxidative resistant;Mi Lihan; Fan Meiling; Tianjia Liu; Donglu Wu; Wang Yang ... Liu Da* ...202213Frontiers in Pharmacology;IF: 4.4
19.Corrigendum: Applications of chitosan and its derivatives in skin and soft tissue diseases;Xia Yidan; Wang Dongxu; Liu Da; Jiayang Su; Ye Jin ...;202210Frontiers in Bioengineering and Biotechnology;IF: 4.3
20.Research progress on anti-ovarian cancer mechanism of miRNA regulating tumor microenvironment
Minghua Cui; Yuehui Liu; Cheng Li; Tao Li; Yongzhi Deng* ... Liu Da* ...;202213;Frontiers in Immunology;IF: 5.7
21.Exosomes in the tumor microenvironment: Promoting cancer progression;Ye Jin; Jianming Xing; Xu Kejin; Liu Da*; Yue Zhuo*;202213;Frontiers in Immunology;IF: 5.7
22.Natural products exert anti-tumor effects by regulating exosomal ncRNA;Hu Shuang; Liu Yi; Guan Shuguang; Zhidong Qiu*; Liu Da*;202212Frontiers in Oncology;IF: 3.5
23...-70...
文件上传中...